#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma recurrent Haemophilia A without inhibitors Acromegaly Langerhans' cell histiocytosis Cholangiocarcinoma Cold type haemolytic anaemia Non-small cell lung cancer Brain stem glioma Acute graft versus host disease in intestine Ovarian cancer stage III Diffuse large B-cell lymphoma recurrent Hyperchylomicronaemia Round cell liposarcoma Fibrodysplasia ossificans progressiva Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Diagnostics Wolfram syndrome – Basic Information Angiosarcoma – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Idiopathic inflammatory myopathy – Trials in Disease Undifferentiated sarcoma Adrenogenital syndrome – Diagnostics Rhabdomyosarcoma recurrent – Treatment Basal cell naevus syndrome – Trials in Disease Ehlers-Danlos syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Macrogol 4000 Gallium (68Ga) Chloride Vsf1.01 Vinflunine Bimekizumab Emiplacel Calcitriol Sodium Glycocholate E.coli Polysaccharide Brodalumab Dexmedetomidine Nicotinamide Bp Opevesostat Benztropine Mesylate Festuca Rubra Pollen Sumatriptan Succinate Prednisolone Sodium Phosphate Posdinemab ACETYLCARNITINE HYDROCHLORIDE ZELENECTIDE PEVEDOTIN More therapies…

    Learn about Your Condition

    Ear discomfort Bacterial vaginosis Dyslipidaemia Delirium Hereditary optic atrophy Benign neoplasm of ureter Anaemia Mitochondrial myopathy Myxoid liposarcoma Cervix carcinoma stage II Juvenile absence epilepsy Cold urticaria Prinzmetal angina Sarcoma Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Golimumab
    France Italy Poland

  • Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Czechia Hungary Italy Poland +1

  • Long-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    Hungary

  • Study on Vedolizumab for Patients with Active Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Belgium France Italy The Netherlands Poland

  • Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Tamuzimod Acetate
    Bulgaria Czechia Germany Hungary Italy Lithuania +2

  • Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium Bulgaria Czechia Estonia France Germany +8
Previous Page
1 … 11 12 13 14 15 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!